Not What Was Expected

The first uses of the vaccine started on Monday, mostly being administered to healthcare workers. As theorized, there was no massive increase in the stocks of both Pfizer ($PFE) and Moderna ($MRNA). The stocks are actually dropping in share price. While this may be collectively bizarre, short term call option owners are probably scrambling, however, long term investors should not fret, as the vaccines will most likely remain steady or rise in share price as the widespread use of the vaccine increases in the next months.

-Darnel Shillingford

Leave a Reply

%d bloggers like this: